Shanghai OuDaXin New Material Technology Center
Tirzepatide
Finnrick tested 3 samples of Tirzepatide (GLP-1 and GIP antagonist) from Shanghai OuDaXin New Material Technology Center between 3 Jun 2025 and 11 Jun 2025. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).
Finnrick Rating™
Tentative Rating
Shanghai OuDaXin New Material Technology Center
Tirzepatide
Tested 3 Samples
Last test 11 Jun 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from Shanghai OuDaXin New Material Technology Center
Samples are tested in commercial labs
Tests Count
3
Scores
AVGMINMAX
Last
11 Jun 2025
First
3 Jun 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 11 Jun 2025 | View | 15mg | 14.700mg | -2.0% | 99.84% | (no batch ID) | Silver Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 11 Jun 2025 | View | 20mg | 16.800mg | -16.0% | 99.64% | (no batch ID) | Silver Label / Silver Crimp / Grey Cap | Lab E | Public | |
| 3 Jun 2025 | View | 40mg | 34.900mg | -12.8% | 99.79% | (no batch ID) | No Label / Silver Crimp / Red Cap | Lab E | Public | |